Emzumab 150mg Injection
Marketer
Cipla Ltd
Salt Composition
Omalizumab (150mg)
Overview Emzumab 150mg Injection
Reslizumab 150mg injection, a monoclonal antibody therapy, treats moderate-to-severe asthma in adults and children. It alleviates asthma symptoms like wheezing, shortness of breath, chest tightness, and coughing. Administered via injection under medical supervision, the initial three doses are given by a physician. Your doctor will instruct you on home injection techniques, determining the optimal dosage for symptom improvement. Continue treatment as prescribed, even if feeling better. Common side effects include arthralgia, pain, tiredness, vertigo, bone fracture, pruritus, eczema, upper abdominal discomfort, nasopharyngitis, cephalalgia, and otalgia. Report bothersome or serious side effects to your physician; mitigation strategies may be available. Note: This medication doesn't prevent acute attacks; always carry your rescue inhaler. Inform your doctor of any liver or kidney disease, pregnancy, or pregnancy plans before starting treatment. List all other medications you're taking, as interactions can reduce efficacy or alter the drug's effects. Alcohol consumption is generally discouraged during treatment. A patient support program is available in India through Tata 1mg; contact your physician or call (1800-102-1618) for details.
Uses of Emzumab 150mg Injection
Respiratory disorder characterized by airway inflammation
Major Benefits of Emzumab 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Emzumab 150mg Injection:
- Joint pain
- Pain
- Fatigue
- Dizziness
- Fracture
- Itching
- Dermatitis
- Upper abdominal pain
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Ear pain
How to use Emzumab 150mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Emzumab 150mg Injection works:
The injectable medication Emzumab (150mg) is a monoclonal antibody targeting immunoglobulin E proteins, crucial mediators in the development of asthma.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Emzumab 150mg Injection.
PregnancySAFE IF PRESCRIBED
The use of 150mg Emzumab injections during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; data from human trials, however, remain scarce.
Breast feedingCONSULT YOUR DOCTOR
The administration of 150mg Emzumab Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Emzumab 150mg Injection.
KidneySAFE IF PRESCRIBED
The use of Emzumab 150mg Injection in patients with kidney disease appears to pose minimal risk. Current evidence indicates that dose modification might not be necessary for this patient population. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Emzumab 150mg Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Emzumab 150mg Injection :
NA
Facts to Know About Emzumab 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Action Class | Monoclonal anti-IgE antibodies |
3,018 People bought this recently